Gene expression profiling of 1p35-36 genes in neuroblastoma

被引:49
作者
Janoueix-Lerosey, I
Novikov, E
Monteiro, M
Gruel, N
Schleiermacher, G
Loriod, B
Nguyen, C
Delattre, O
机构
[1] Inst Curie, U509, INSERM, Sect Rech,Lab Pathol Mol Canc, F-75248 Paris 05, France
[2] Ctr Immunol Marseille Luminy, Equipe TAGC, F-13288 Marseille, France
关键词
neuroblastoma; 1p deletion; gene expression profiling; hierarchical clustering;
D O I
10.1038/sj.onc.1207784
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deletion of the chromosome 1p36 region is a frequent abnormality in neuroblastoma. To gain further insights into the role of this alteration in oncogenesis, we have constructed a specific cDNA microarray representing most known genes and ESTs from the 1p35-36 region and analysed the expression profiles of 15 neuroblastoma cell lines and 28 neuroblastoma tumours. Hierarchical clustering using expression levels of 320 cDNAs from 1p35-36 separated localized or 4S cases without 1p deletion from advanced stages and cell tines. Supervised learning classification enabled to predict reliably the status of chromosome 1p according to its expression profile. Around 15% of the genes or ESTs presented a significantly decreased expression in samples with 1p deletion as compared to 1p-normal samples suggesting that 1p deletion results in a gene dosage effect on a subset of genes critical for the development of 1p-deleted neuroblastoma. Several genes presumed to have functions in neural differentiation (CDC42, VAMP3, CLSTN1), signal transduction in neural cells (GNB1) and cell cycle regulation (STMN1, RPA2, RBAF600, FBXO6, MAD2L2) exhibited a decreased expression in samples presenting 1p deletion. The identification of such genes provides baseline information for further studies to elucidate how these genes could individually or collectively play a critical role in neuroblastoma tumorigenesis.
引用
收藏
页码:5912 / 5922
页数:11
相关论文
共 31 条
[1]   Smallest region of overlapping deletion in I p36 in human neuroblastoma: A I Mbp cosmid and PAC contig [J].
Bauer, A ;
Savelyeva, L ;
Claas, A ;
Praml, C ;
Berthold, F ;
Schwab, M .
GENES CHROMOSOMES & CANCER, 2001, 31 (03) :228-239
[2]   Gene expression profiling of primary breast carcinomas using arrays of candidate genes [J].
Bertucci, F ;
Houlgatte, R ;
Benziane, A ;
Granjeaud, S ;
Adélaïde, J ;
Tagett, R ;
Loriod, B ;
Jacquemier, J ;
Viens, P ;
Jordan, B ;
Birnbaum, D ;
Nguyen, C .
HUMAN MOLECULAR GENETICS, 2000, 9 (20) :2981-2991
[3]  
BIEGEL JA, 1993, AM J HUM GENET, V52, P176
[4]  
Bo TH, 2002, GENOME BIOL, V3
[5]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[6]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[8]  
CHENG NC, 1995, ONCOGENE, V10, P291
[9]   SENSITIVE DETECTION OF NUMERICAL AND STRUCTURAL-ABERRATIONS OF CHROMOSOME-1 IN NEUROBLASTOMA BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION - COMPARISON WITH RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND CONVENTIONAL CYTOGENETIC ANALYSES [J].
COMBARET, V ;
TURCCAREL, C ;
THIESSE, P ;
REBILLARD, AC ;
FRAPPAZ, D ;
HAUS, O ;
PHILIP, T ;
FAVROT, MC .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (02) :185-191
[10]   Rho GTPases in growth cone guidance [J].
Dickson, BJ .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (01) :103-110